BioCryst Pharmaceuticals
BCRX
BCRX
191 hedge funds and large institutions have $1.06B invested in BioCryst Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 57 increasing their positions, 71 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
191
Holders Change
+14
Holders Change %
+7.91%
% of All Funds
3.36%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
46
Increased
57
Reduced
71
Closed
31
Calls
$37.2M
Puts
$23.2M
Net Calls
+$13.9M
Net Calls Change
+$15.9M
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
$49.7M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
$30.8M |
| 3 |
Goldman Sachs
New York
|
$22.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
$14.6M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
$25.5M |
